Efficacy of hepatitis B vaccination and interferon‐α‐2b combination therapy versus interferon‐α‐2b monotherapy in children with chronic hepatitis B

Abstract

Although the difference was statistically insignificant, the sustained response rates were better in the combination therapy group than in the monotherapy group. The potential benefit of combining IFN and hepatitis B vaccine should be investigated in further studies with different regimens of combination therapy.